News Conference News HFSA 2023 Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships Shelley Wood October 13, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2023 Shelley Wood March 01, 2023
News Daily News HF Specialists Detail ‘Road Map’ for Improving HF Training Pipeline Shelley Wood January 04, 2023
News Features Heart Failure Care Has a Pipeline Problem: What’s the Fix? Shelley Wood December 20, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions Shelley Wood August 15, 2022
News Opinion Fellow Talk Five Things I Wish I Knew at the Beginning of My General Cardiology Training Yuvraj S. Chowdhury, MD July 07, 2022
News Opinion Fellow Talk Don’t Expect Success in Interventional Cardiology, Prepare for It! Yuvraj S. Chowdhury, MD February 24, 2022
News Features World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard Shelley Wood December 13, 2021
News Daily News Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map Shelley Wood June 11, 2021
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Daily News Female Mentors Likely Play Key Role in Boosting Numbers of Female ‘Corresponding’ Authors Shelley Wood February 21, 2019
News Daily News Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand Shelley Wood November 22, 2018
News Conference News ACC Survey: More Than One in Four Cardiologists Report Burnout Shelley Wood November 20, 2017
News Conference News EuroPCR 2017 EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40 Shelley Wood May 12, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017